MAPT and amyloidosis: Positron emission tomography (PET) is another promising tool to identify abnormal brain metabolism (18F-FDG PET) [39] and to detect amyloid deposition (Amyloid PET) [40,41,42,43] and disease staging with amyloid and tau PET [44].